Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smiti Bihari

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Infection|May 29, 2016
Immunisation of the immunocompromised childMarta Valente Pinto, Smiti Bihari, Matthew D Snape
The Pediatric Infectious Disease Journal|June 2, 2012
Interferon gamma-induced protein-10 concentrations in children with previous tuberculosis infections and diseaseSmiti Bihari, Nara Cavalcanti, Jailson B Correia, et al.
NPJ Vaccines|July 13, 2023
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in childrenDmitri Kazmin, Elizabeth A Clutterbuck, Giorgio Napolitani, et al.
Infectious Diseases and Therapy|March 15, 2024
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 VaccinationTimothy E Albertson, Caitlin Hansen, Smiti Bihari, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Infection|May 29, 2016
Immunisation of the immunocompromised childMarta Valente Pinto, Smiti Bihari, Matthew D Snape
The Pediatric Infectious Disease Journal|June 2, 2012
Interferon gamma-induced protein-10 concentrations in children with previous tuberculosis infections and diseaseSmiti Bihari, Nara Cavalcanti, Jailson B Correia, et al.
NPJ Vaccines|July 13, 2023
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in childrenDmitri Kazmin, Elizabeth A Clutterbuck, Giorgio Napolitani, et al.
Infectious Diseases and Therapy|March 15, 2024
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 VaccinationTimothy E Albertson, Caitlin Hansen, Smiti Bihari, et al.
Pageof 1